
Introduction
This webinar features leading global thought leaders who assess the evolution of AF ablation through focused lectures and discussions that evaluate the potential impact of emerging LAA and Hybrid therapies for improving outcomes in clinical practice. Each lecture is complemented with a corresponding Q&A session, during which time the presenters address attendee questions. The webinar concludes with a panel discussion, led by the moderators, Dr. Dhanunjaya Lakkireddy and Dr. Andrea Natale, who are joined by the panelists who address questions and engage in a roundtable discussion.
Agenda
![]() |
Viewing Options: |
Agenda |
Welcome and Introductions |
AF Substrate Beyond the Pulmonary Veins |
Hybrid Epi/Endo Ablation of AF |
Implications of the aMAZE trial for Clinical Practice |
Panel Discussion |
Educational grant support provided by:
AtriCure.
Joint Providership
MediaSphere Medical, LLC and Ciné-Med
Sponsor
This educational activity is Sponsored and Endorsed by:
The International Symposium on Left Atrial Appendage (ISLAA)
Faculty
Moderators |
|||
![]() |
Dhanunjaya Lakkireddy, MD |
![]() |
Andrea Natale, MD |
Presenters and Panelists |
|||
![]() |
Wendy Tzou, MD |
![]() |
Felix Yang, MD |
![]() |
David Wilber, MD |
||
Panelists |
|||
![]() |
Luigi Di Biase, MD, PhD |
![]() |
Ahmed Romeya, MD |
![]() |
Kevin Makati, MD |
![]() |
David Tschopp, MD |